Russell Skibsted

Russell L.
Skibsted is currently Chief Financial Officer at Processa Pharmaceuticals, Inc. since 2024.
Former roles include Chief Financial Officer & Senior Vice President at Alimera Sciences, Inc. (2023–2024), Chief Financial Officer at Asterias Biotherapeutics, Inc. (2016), Chief Financial & Accounting Officer at Insight Molecular Diagnostics, Inc. (2015–2017), Chief Financial & Accounting Officer at Lineage Cell Therapeutics, Inc. (2015–2019), Chief Financial Officer at Proove Biosciences, Inc. (2013–2015), Chief Financial Officer, Secretary, CAO & SVP at Aeolus Pharmaceuticals, Inc. (2013), Chief Financial Officer & Managing Director at RSL Venture Partners LP (2013–2014), Chief Financial Officer & Executive Vice President at Pharmagen, Inc. (2014), Chief Financial Officer at Talon Therapeutics, Inc. (2004–2006), Chief Financial Officer & Partner at Asset Management Co. (2000–2004), Chief Business Officer & Senior Vice President at Spectrum Pharmaceuticals, Inc. (2006–2009), Executive VP, Chief Financial & Business Officer at Rockwell Medical, Inc., Director-Corporate Development at Pinkerton, Inc., Vice President at GE Capital Services, and Chief Financial Officer at AgeX Therapeutics, Inc. Education includes undergraduate studies at Claremont McKenna College and an MBA from Stanford Graduate School of Business.